BSX vs CRNX · P/E 20, rev $20.07B vs rev $35.9M
Boston Scientific Corp (BSX) versus Crinetics Pharmaceuticals Inc (CRNX) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CRNX currently screens at market cap $2.76B.
Not investment advice. Open the BSX and CRNX stock pages for the full models.
Not investment advice.